Le Ribeuz, Hélène
Courboulin, Audrey
Ghigna, Maria-Rosa
Lambert, Mélanie
Hautefort, Aurélie
Humbert, Marc
Montani, David
Cohen-Kaminsky, Sylvia
Perros, Frédéric
Antigny, Fabrice http://orcid.org/0000-0002-9515-6571
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-18-CE14-0023)
Article History
Received: 22 April 2020
Accepted: 6 July 2020
First Online: 16 July 2020
Ethics approval and consent to participate
: This study was approved by the Committee on the Ethics of Animal Experiments (CEEA26 CAP Sud). The animal experiments were performed conforming to the guidelines from Directive 2010/63/EU on 22 September 2010 of the European Parliament on the protection of animals used for scientific purposes and complied with the French institution’s guidelines for animal care and handling.
: Not applicable.
: M.H. has relationships with drug companies, including Actelion, Bayer, GSK, Novartis, and Pfizer. In addition to being investigator in trials involving these companies, other relationships include consultancy services and memberships to scientific advisory boards. The other authors have no conflicts of interest.